SARUTA Takao | Keio University

スポンサーリンク

概要

関連著者

もっと見る

著作論文

The Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension
Effects of Cardiac Complications on Cardiovascular Events in Japanese High-Risk Hypertensive Patients : Subanalysis of the CASE-J Trial
Relationship between the achieved blood pressure and the incidence of cardiovascular events in Japanese hypertensive patients with complications : a sub-analysis of the CASE-J trial
Role of diabetes and obesity in outcomes of the candesartan antihypertensive survival evaluation in Japan (CASE-J) trial
1 Which Risk Factor Has an Adverse Effect on Coronary Events in Japanese High-risk Hypertensive Patients? : a Subanalysis of CASE-J(Comprehensive Risk Management for Prevention of Coronary Artery Disease,Symposium 16 (SY-16) (H),The 73rd Annual Scientific
4 On-going Japanese Clinical Trials for Hypertension II : Seeking for More Effective Pharmacological Treatment(ESC-JCS Joint Symposium (ESC-JCS Joint Symposium) (H) Evidence-Based Medical Treatment of Hypertension,Special Program,The 72nd Annual Scientifi
Nifedipine Retard Was as Effective as Angiotensin Converting Enzyme Inhibitors in Preventing Cardiac Events in High-Risk Hypertensive Patients with Diabetes and Coronary Artery Disease : The Japan Multicenter Investigation for Cardiovascular Diseases-B (J
3 Clinical Outcomes in Hypertensive Patients with High Cardiovascular Risks : Principal Results of Candesartan Antihyopertensive Survival Evaluation in Japan (CASE-J) Study(Late Breaking Clinical Trials in Japan, The 71st Annual Scientific Meeting of the
Impact of Left Ventricular Hypertrophy on the Time-Course of Renal Function in Hypertensive Patients : A Subanalysis of the CASE-J Trial
The Optimal Target Blood Pressure for Antihypertensive Treatment in Japanese Elderly Patients with High-Risk Hypertension : A Subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial
Rationale, study design and implementation of the COLM study : the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients
Comparison of Nifedipine Retard with Angiotensin Converting Enzyme Inhibitors in Japanese Hypertensive Patients with Coronary Artery Disease : The Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) Randomized Trial
OE-141 Cardio-cerebral and Cardio-renal Complications in High-risk Hypertensive Patients with Cardiac Risks Based on the Results of CASE-J Trial(Hypertension, clinical(01)(H),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Ci
FRS-003 Prognostic Value of Left Ventricular Hypertrophy and Changes in Left Ventricular Mass in Hypertensive Patients : An analysis of CASE-J Trial(New Clinical Aspects for Hypertension(H),Featured Research Session,The 72nd Annual Scientific Meeting of t
1 To Make the Best Use of Japanese Evidences to Future Guidelines : From the Results and Experiences of CASE-J Trial(Symposium 18 (SY-18) (H) How can we Make the Best Use of Japanese Evidences for Future Guidelines,Special Program,The 72nd Annual Scientif
Influence of Coronary Risk Factors on Coronary Events in Japanese High-Risk Hypertensive Patients : Primary and Secondary Prevention of Ischemic Heart Disease in a Subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial
Long-term effects of candesartan and amlodipine on cardiovascular morbidity and mortality in Japanese high-risk hypertensive patients : the Candesartan Antihypertensive Survival Evaluation in Japan Extension Study (CASE-J Ex)
Combination therapy for hypertension in the elderly : a sub-analysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial

もっと見る

スポンサーリンク